As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

India cephalexin market is expected to grow at a steady rate during the forecast period. The India cephalexin market is driven by the growing use of the drug in treatment of upper respiratory infection, skin infections, urinary tract infections, among others. Additionally, the antibiotic can be used as an alternative in patients who are having mild or moderate allergy to penicillin. This in turn is expected to propel the market through FY2026. Furthermore, safety, efficacy and affordability factors associated with cephalexin are expected to fuel the market growth over the next few years.

The India cephalexin market is segmented based on source, form, route of administration, distribution channel, application, end user, company and region. Based on route of administration, the market can be split into oral and intravenous. The intravenous route is expected to witness significant growth during the forecast period since a high dose of drug can be administered to the patient using this route. Additionally, this route has 100% bioavailability and helps in achieving the desired concentration of the drug in bloodstream.

The major players operating in the India cephalexin market are Medico Remedies Ltd., Dabur Pharma Ltd., Ajanta Pharma Ltd., Aristo Pharmaceuticals Pvt. Ltd., Aurobindo Pharma Ltd., Sun Pharmaceuticals Industries Ltd., Cadila Pharmaceuticals Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Centurion Laboratories Private Ltd., Alkem Laboratories Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, portfolio expansion and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India cephalexin market from FY2016 to FY2019.
  • To estimate and forecast the market size of India cephalexin market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India cephalexin market based on source, form, route of administration, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India cephalexin market.
  • To identify drivers and challenges for India cephalexin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India cephalexin market.
  • To identify and analyze the profile of leading players operating in India cephalexin market.
  • To identify key sustainable strategies adopted by market players in India cephalexin market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India cephalexin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Cephalexin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to cephalexin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India cephalexin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Cephalexin Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Cephalexin Market, By Form:
    • Tablet
    • Capsule
    • Liquid Suspension
    • Injection
    • Others
  • India Cephalexin Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Cephalexin Market, By Distribution Channel:
    • Online
    • Offline
  • India Cephalexin Market, By Application:
    • Respiratory Tract Infections
    • Otitis Media
    • Skin and Skin Structure Infections
    • Bone Infections
    • Genitourinary Infections
    • Others
  • India Cephalexin Market, By End User:
    • Adult
    • Pediatric
  • India Cephalexin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India cephalexin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Cephalexin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at  

In case you don’t find what you are looking for, please get in touch with our custom research team at

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Cephalexin Market

4.    Executive Summary

5.    Manufacturing Cephalexin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Cephalexin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Cephalexin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.2.     By Form (Tablet, Capsule, Liquid Suspension, Injection, Others)

7.2.3.     By Route of Administration (Oral v/s Intravenous)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Application (Respiratory Tract Infections, Otitis Media, Skin and Skin Structure Infections, Bone Infections, Genitourinary Infections, Others)

7.2.6.     By End User (Adult v/s Pediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Medico Remedies Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Dabur Pharma Ltd.

14.1.3.  Ajanta Pharma Ltd.

14.1.4.  Aristo Pharmaceuticals Pvt. Ltd.

14.1.5.  Aurobindo Pharma Ltd.

14.1.6.  Sun Pharmaceuticals Industries Ltd.

14.1.7.  Cadila Pharmaceuticals Ltd.

14.1.8.  GlaxoSmithKline Pharmaceuticals Ltd.

14.1.9.  Centurion Laboratories Private Ltd.

14.1.10.                Alkem Laboratories Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer 

In case you don’t find what you are looking for, please get in touch with our custom research team at